Expression of AURKA, MYBL2, or ZNF217 was not associated with drug resistance in our pancancer analysis of cell lines, which may suggest that the association between the copy number of imprinted genes at the 20q11-q13.32 and cancer drug resistance may not be due to the direct effects of these non-imprinted genes. The gene discussed is MYBL2; the disease is cancer.